x
ServiziMenu principaleHome
You are here: Home > Task Forces > Cachexia in cancer patients
Print

ESO Task Force on early diagnosis of Cachexia in the cancer patients

Diagnosing and managing cachexia in cancer patients needs an independent review with the aim of establishing the level of evidence available for possible recommendations for oncological clinical practice with special regard to the identification of this condition at the early stage of its development.

Formed in 2012, the objectives of this task force are to raise awareness in the area of nutrition/cachexia in medical oncology and to come out with a common message for the definition of cachexia as well as a classification and staging system.

Progress to Date

Production of a position paper, Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force, has been published in Annals of Oncology online on 25 February 2014 and in print in the August 2014 issue.

Future plans

The Task Force aims to:

The Task Force

The Task Force is chaired by Matti Aapro (CH).
Members of the expert group are: Jann Arends (DE), Federico Bozzetti (IT), Ken Fearon (UK), Jorn Herrstedt (DK), Jane Hopkinson (UK), Jean-Claude Horiot (CH), Aminah Jatoi (USA), Nathalie Jacquelin-Ravel (CH), Stein Kaasa (NO), Florian Strasser (CH).

For further information, please contact:
Alexandra Zampetti
azampetti@eso.net

Helsinn Healthcare, a sustaining member of the Sharing Progress in Cancer Care (SPCC) programme, has provided an unrestricted grant towards ESO for this initiative. SPCC is a pioneering partnership between the European School of Oncology (ESO) and some of the world’s leading pharmaceutical companies.

Follow us